X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ALEMBIC LTD ALKEM LABORATORIES/
ALEMBIC LTD
 
P/E (TTM) x - 78.5 - View Chart
P/BV x 6.3 2.9 216.9% View Chart
Dividend Yield % 0.7 0.4 178.1%  

Financials

 ALKEM LABORATORIES   ALEMBIC LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ALEMBIC LTD
Mar-16
ALKEM LABORATORIES/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,58953 3,009.5%   
Low Rs1,23229 4,204.8%   
Sales per share (Unadj.) Rs417.54.7 8,845.0%  
Earnings per share (Unadj.) Rs56.38.8 641.6%  
Cash flow per share (Unadj.) Rs64.79.0 718.7%  
Dividends per share (Unadj.) Rs12.700.15 8,466.7%  
Dividend yield (eoy) %0.90.4 246.4%  
Book value per share (Unadj.) Rs292.927.7 1,056.5%  
Shares outstanding (eoy) m119.57267.03 44.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.48.7 38.8%   
Avg P/E ratio x25.14.7 535.5%  
P/CF ratio (eoy) x21.84.6 478.1%  
Price / Book Value ratio x4.81.5 325.2%  
Dividend payout %22.61.7 1,319.5%   
Avg Mkt Cap Rs m168,65310,962 1,538.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,171238 3,853.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,9151,260 3,960.6%  
Other income Rs m1,645264 623.6%   
Total revenues Rs m51,5611,524 3,383.0%   
Gross profit Rs m8,48283 10,244.3%  
Depreciation Rs m1,00661 1,638.1%   
Interest Rs m6710 223,533.3%   
Profit before tax Rs m8,451285 2,966.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m1,6066 26,327.9%   
Profit after tax Rs m6,7312,343 287.3%  
Gross profit margin %17.06.6 258.7%  
Effective tax rate %19.02.1 887.6%   
Net profit margin %13.5185.9 7.3%  
BALANCE SHEET DATA
Current assets Rs m27,0621,689 1,602.4%   
Current liabilities Rs m15,324486 3,151.7%   
Net working cap to sales %23.595.4 24.6%  
Current ratio x1.83.5 50.8%  
Inventory Days Days67217 30.7%  
Debtors Days Days4181 50.9%  
Net fixed assets Rs m12,6101,624 776.4%   
Share capital Rs m239534 44.8%   
"Free" reserves Rs m34,4905,960 578.7%   
Net worth Rs m35,0277,404 473.1%   
Long term debt Rs m1,212104 1,161.6%   
Total assets Rs m54,3878,010 679.0%  
Interest coverage x13.6950.7 1.4%   
Debt to equity ratio x00 245.5%  
Sales to assets ratio x0.90.2 583.3%   
Return on assets %13.629.3 46.5%  
Return on equity %19.231.6 60.7%  
Return on capital %24.931.3 79.4%  
Exports to sales %12.92.9 439.7%   
Imports to sales %3.128.9 10.7%   
Exports (fob) Rs m6,46137 17,415.4%   
Imports (cif) Rs m1,540364 423.5%   
Fx inflow Rs m6,56337 17,690.8%   
Fx outflow Rs m3,012365 825.3%   
Net fx Rs m3,552-328 -1,083.3%   
CASH FLOW
From Operations Rs m7,259346 2,100.3%  
From Investments Rs m1,864-48 -3,916.4%  
From Financial Activity Rs m-9,273-301 3,080.6%  
Net Cashflow Rs m-150-3 5,000.0%  

Share Holding

Indian Promoters % 66.9 64.0 104.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.2 16,550.0%  
FIIs % 0.0 9.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 26.1 -  
Shareholders   68,381 54,701 125.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Pares Gains; Telecom Stocks Rally(01:30 pm)

After opening the day on a firm note, the Indian share markets pared its morning gains to trade flat. Sectoral indices are trading mixed, with stocks in the realty sector.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Why Merger of Public Sector Banks Continues to Be a Bad Idea(Vivek Kaul's Diary)

Oct 10, 2017

There is enough research evidence that suggests that most mergers don't work.

Electric Vehicles: The Final Piece of the Puzzle(Smart Contrarian)

Oct 16, 2017

Just as there would be gainers from an electric vehicles boom, who possibly could be the biggest losers.

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

Companies Are Wary of Borrowing(Chart Of The Day)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 23, 2017 02:50 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS